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A B S T R A C T
The Vitek 2 system was assessed against refer-
ence methods with 197 methicillin-resistant Sta-
phylococcus aureus from Belgian hospitals and 121
clinically significant blood culture isolates of
Staphylococcus spp. Vitek 2 identified 95% of
staphylococcal isolates correctly, detected oxacil-
lin resistance with a sensitivity/specificity of 99/
96%, and showed acceptable accuracy for sus-
ceptibility testing of five of eight other evaluable
antibiotics. The median time for reporting results
was 2 h 45 min for identification and 7 h for
susceptibility tests.
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Methicillin-resistant strains of Staphylococcus
aureus (MRSA) are important pathogens causing
nosocomial and community-acquired infections
[1]. Some coagulase-negative staphylococci
(CNS), such as Staphylococcus epidermidis and
Staphylococcus haemolyticus, are also frequently
methicillin- and multidrug-resistant [2] and cause
bloodstream and device-related infections. Inva-
sive isolates of staphylococci should therefore be
identified to the species level to determine their
clinical relevance and to monitor their epidemi-
ology [2]. Methicillin and b-lactam resistance in
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staphylococci is related to the production of
penicillin-binding protein (PBP) 2a encoded by
the mecA determinant [1]. Heterogeneous expres-
sion of mecA makes detection by phenotypic
methods difficult in some resistant strains, requi-
ring incubation for a full 24 h or the use of inducer
substrates such as cefoxitin.
The objectives of this study were to evaluate the
Vitek 2 system (bioMe´rieux, Lyon, France) Gram-
positive identification (ID-GPC) and susceptibility
testing (AST-P507) cards for identification of
clinically significant isolates of staphylococci,
detection of oxacillin resistance, and testing of
susceptibility to other anti-staphylococcal antibi-
otics.
In total, 318 isolates of Staphylococcus spp. were
studied, comprising 197 MRSA isolates from the
National MRSA Surveillance Programme [3], and
121 clinically significant [4] Staphylococcus spp.
isolates from blood culture (76 S. aureus, 35
S. epidermidis, three S. haemolyticus, three Staphy-
lococcus lugdunensis, two Staphylococcus hominis,
one Staphylococcus schleiferi and one Staphylococcus
intermedius) obtained during 1998. Thirty-four
(45%) S. aureus and 29 (83%) S. epidermidis were
resistant to oxacillin.
The Vitek 2 identification results obtained with
the ID-GPC card were compared with those
obtained by a combination of phenotypic and
genotypic tests, including coagulase tests (human
plasma), multiplex PCR for the mecA and nuc
genes, and ATB ID 32 STAPH (bioMe´rieux) for
CNS [5]. Each series of identification tests included
the reference strains Enterococcus casseliflavus
ATCC 700327, Kocuria rosea ATCC 186, S. aureus
ATCC 29213, S. lugdunensis ATCC 700328, Staphy-
lococcus sciuri ATCC 29061, Streptococcus pneumo-
niae ATCC 6301 and Streptococcus uberis ATCC
9927. Tests were repeated following discrepant or
inconclusive results, with identification to the
species level by analysis of tRNA intergenic spacer
polymorphism [6] where necessary. The accept-
able level of correct identification was set at 90%.
Vitek 2 susceptibility results obtained with the
AST-P507 card and analysed with the Advanced
Expert System software (v.1.0) were compared
with those obtained with oxacillin screen agar
(Becton Dickinson, Cockeysville, MD, USA),
detection of mecA by PCR [5] and agar dilution
MICs following NCCLS guidelines [7] for 11
antibiotics (Table 1). Susceptibility tests for ofl-
oxacin and quinupristin-dalfopristin could not be
compared because some isolates were not tested
by the reference method. Each test series included
reference strains S. aureus ATCC 29213 (oxacillin-
susceptible) and ATCC 33592 (oxacillin-resistant,
mecA-positive). Tests were repeated in the case of
discrepancies between Vitek 2 and the reference
methods. Acceptable accuracy was defined
as: <3% very major errors (susceptible for
resistant) and <3% major errors (resistant for
susceptible); >90% agreement of MICs within one
two-fold dilution; and Youden’s J statis-
tic = >0.90, defined by the formula (sensitivity +
specificity ) 1), ranging from )1 for complete
discordance to 1 for complete concordance.
The Vitek 2 instrument identified correctly 111
(92%) of 121 bloodstream isolates of staphylo-
cocci: 74 (97%) of 76 S. aureus, 31 (89%) of 35
S. epidermidis, and six of ten other CNS species.
Unidentified non-epidermidis CNS isolates were
S. haemolyticus (n = 1), S. hominis (n = 2) and
S. schleiferi (n = 1). After repeated testing, 95%
of isolates were identified correctly, with results
Table 1. Diagnostic accuracy of the Vitek 2 system for detection of resistance to 11 antibiotics with Staphylococcus spp.
isolates (n = 318) tested in comparison with reference methods
Antibiotic
Sensitivity Specificity No. (%) of interpretive errors
Youden’s J
statisticbNo. reported/No. R % No. reported/No. S % Very major Major Minor
Oxacillin 263 ⁄ 265 99.2 51 ⁄ 53 96.2 0 2 (0.6) 0 0.954
Vancomycin 0 ⁄ 0 NAa 318 ⁄ 318 100 0 0 0 NA
Teicoplanin 0 ⁄ 2 NA 315 ⁄ 315 100 1 (0.3) 0 2 (0.6) NA
Gentamicin 130 ⁄ 135 96.3 179 ⁄ 179 100 1 (0.3) 0 5 (1.6) 0.963
Tobramycin 161 ⁄ 165 97.6 134 ⁄ 136 98.5 0 1 (0.3) 19 (6.0) 0.961
Erythromycin 193 ⁄ 193 100 116 ⁄ 117 99.1 0 0 3 (0.9) 0.991
Lincomycin 133 ⁄ 142 93.7 158 ⁄ 164 96.3 2 (0.6) 3 (0.9) 13 (4.1) 0.900
Tetracycline 132 ⁄ 132 100 180 ⁄ 183 98.4 0 2 (0.6) 1 (0.3) 0.984
Fusidic acid 6 ⁄ 8 NA 302 ⁄ 302 100 1 (0.3) 0 2 (0.6) NA
Rifampicin 36 ⁄ 36 100 213 ⁄ 264 80.7 0 27 (8.5) 38 (11.9) 0.807
Trimethoprim-
sulphamethoxazole
20 ⁄ 23 87 295 ⁄ 295 100 3 (0.9) 0 0 0.870
aNA, not applicable because of insufficient number of resistant strains; bYouden’s J statistic = sensitivity + specificity ) 1 (ranging from )1, complete disagreement, to +1,
complete agreement); R, resistant; S, sensitive.
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reported after a time varying between 1 h 45 min
and 6 h (median, 2 h 15 min), which compared
favourably with other rapid phenotypic systems
[8] and molecular methods that require special
hybridisation, electrophoretic or sequencing
equipment [6,9,10]. Further evaluation of the
Vitek 2 ID-GPC card is required for identification
of CNS species that are encountered less fre-
quently in clinical specimens, including S. haemo-
lyticus and S. hominis.
The Vitek 2 also showed excellent accuracy for
detection of oxacillin-resistant S. aureus and CNS
isolates (99.2% sensitivity and 96.2% specificity in
the first run; Table 1). Two false-negative MRSA
results were obtained, one of which was identi-
fied by the Advanced Expert System software as
‘probable MRSA’ because of growth in the ‘oxa-
cillin control’ well. These two isolates expressed
a class 2 heteroresistant phenotype. Following
repeat testing of these isolates, the sensitivity
reached 100%. In settings with a high prevalence
of heterogeneous class 1–2 MRSA strains, a lower
sensitivity of oxacillin resistance detection testing
has been noted previously with the Vitek 2
system [11].
Among CNS isolates, low-level oxacillin-resist-
ant S. epidermidis (MICs of 0.5–4 mg ⁄L) were
reported accurately. Three mecA-negative S. lugd-
unensis isolates had an oxacillin MIC of 1 mg ⁄L by
the Vitek 2 system, and were reported falsely as
resistant; two of these were oxacillin-susceptible
by agar dilution. S. lugdunensis strains carry mecA
only rarely [18] and, according to the NCCLS
guidelines, mecA-negative S. lugdunensis with
oxacillin MICs of 0.5–2 mg ⁄L should be reported
as susceptible [7]. Overall, detection of oxacillin
resistance by Vitek 2 in this study compared well
with other rapid detection assays [13–18] and
first-generation automated systems such as Rapid
ATB Staph [14,17,19].
The present study was unable to evaluate
susceptibility testing of antibiotics (fusidic acid,
teicoplanin and vancomycin) for which too few
(<20) resistant isolates were available, or of agents
(ofloxacin and quinupristin-dalfopristin) not
tested by the reference method. However, few
(<1%) very major interpretive category errors
were observed among evaluable drugs (Table 1).
The sensitivity of resistance detection by Vitek 2
was >96%, except for lincomycin and co-trim-
oxazole which showed the highest rates of very
major errors (Table 1). The Vitek 2 failed to detect
teicoplanin resistance or intermediate resistance
in three S. haemolyticus isolates. The specificity
was >96%, except for rifampicin (80.7%). Major
error rates ranged from 0.3% for tobramycin to
8.5% for rifampicin (Table 1). Minor errors (inter-
mediate for sensitive) were also encountered most
frequently (11.9%) with rifampicin. MRSA strains
divided into those with high-level resistance to
rifampicin (MICs ‡32 mg ⁄L) and those with low-
level resistance (MICs 1–4 mg ⁄L). The latter group
of isolates showed one- or two-step higher MIC
values with Vitek 2 as compared with agar dilu-
tion. This result was scored as inaccurate, although
it can be argued that borderline susceptible isolates
may easily become rifampicin-resistant, and
should be reported as intermediately resistant by
mechanism-based interpretive reading.
Overall, the Vitek 2 system showed acceptable
accuracy for automated identification and suscep-
tibility testing for a range of antibiotics, including
oxacillin, with staphylococci isolated from Belgian
hospitals. The ability to offer combined rapid
identification and antibiotic susceptibility profiles
for various bacterial species makes this system
attractive to clinical laboratories, although the
laboratory workflow meant that the results of
susceptibility tests were often not available until
the next working day. Further evaluation of the
cost-effectiveness of the system for the microbio-
logical diagnosis and clinical management of
staphylococcal infection is warranted.
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A B S T R A C T
There are very few reports on the rates of
oropharyngeal colonisation by Streptococcus pyo-
genes and Staphylococcus aureus in young adults.
The present study found colonisation rates of
9.6% and 26.2%, respectively. These rates are
two-fold higher than historical rates, indicating
that these organisms may be more prevalent than
thought previously. This finding may have
important clinical consequences in certain popu-
lations, and requires further investigation.
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Numerous studies have investigated the presence
of pathogenic bacteria in the oropharynx of
individuals with symptoms of pharyngitis, but
little is known about the prevalence of such
organisms in the asymptomatic young adult
population. Both Streptococcus pyogenes and Sta-
phylococcus aureus may be present as part of the
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